What You Should Know:
– Power, the company transforming the traditional clinical trial landscape, announced today the close of their $11.9M Series A funding round led by Kin, Contrary, and Footwork.
– The strategic funding fuels…
Continue Reading
Brian Williams, Life Sciences Strategy & Innovation at EPAM Systems, Inc.
Although the traditional nearly decade-long clinical trial timelines completely collapsed during COVID, this truncating was not necessarily novel. Precedent exists for accelerating approval timelines…
Continue Reading
Top News
ONC and The Sequoia Project designate Kno2 and CommonWell Health Alliance as Qualified Health Information Networks under TEFCA. They join Konza National Network, EHealth Exchange, Epic Nexus, Health Gorilla, and MedAllies, which were…
Continue Reading
Adam Goldberger, Chief Financial Officer at QuantHealth
Dr. Adam Petrick, MD, Chief Medical Officer at QuantHealth
What You Should Know:
What You Should Know:
– QuantHealth, an AI-powered clinical trial design company that simulates clinical trials, announced…
Continue Reading
Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced it scored $50 million in Series C funding, bringing its total raise to more than $130 million. Altimeter Capital led the round with…
Continue Reading
What You Should Know: ObvioHealth, a global digital clinical trials company, and Oracle Life Sciences are expanding their partnership globally following the results of a year-long, successful effort launching trials in Asia Pacific.The collaboration will enable…
Continue Reading
What You Should Know:
– H1, the go-to resource for healthcare professionals, clinical trial information, and life sciences research, announced the launch of its conversational AI tool GenosAI Pro.
– The conversational AI tool empowers pharmaceutical…
Continue Reading
In clinical trials, pharmaceutical companies are seeking to optimize operations and improve efficiency by automating and enhancing processes through Artificial Intelligence (AI) and Machine Learning (ML). One area where this can reap tangible benefits…
Continue Reading
What You Should Know:
– 23andMe Holding Co. (Nasdaq: ME), a genetics and biopharmaceutical company, announced The U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for 23ME-01473 (referred to…
Continue Reading
Sano Genetics has raised $11.4m in a new funding round to help power a revolution in precision medicine by deploying artificial intelligence to help streamline the clinical trial process.The Cambridge-based company is building a…
Continue Reading
